CRP and atherosclerosis: The consistent reduction in carotid intima-media thickness (CIMT), aortic pulse wave velocity (aPWV), fat attenuation index (FAI), and inflammatory markers such as C-reactive protein (CRP) highlights the potential of TNF-α inhibitors to not only mitigate the progression of atherosclerosis but also to improve overall vascular health.